A complex duplication overlapping FBRSL1 implicated in a developmental and epileptic encephalopathy

This paper reports the first case of a complex structural variant at the *FBRSL1* locus causing a profound developmental and epileptic encephalopathy, providing evidence for a dominant-negative mechanism and expanding the known phenotypic and genotypic spectrum of *FBRSL1*-related disorders.

The Gist

The Big Picture: A Genetic "Glitch" in the Construction Manual

Imagine your body's DNA is a massive, detailed instruction manual for building a human baby. Inside this manual, there is a specific chapter called FBRSL1. This chapter is crucial for building the brain, the heart, and the muscles, especially while the baby is still in the womb.

In the past, doctors knew that if this chapter was missing or scrambled (a "truncating variant"), it caused severe problems. It was like having a page torn out of the manual; the builders (your cells) didn't know what to do, leading to developmental delays and heart issues.

This paper tells the story of a brand new, very different kind of glitch. Instead of a missing page, the baby had a photocopy error.

The Story of the Baby (The Patient)

The researchers studied a baby girl who was very sick from the moment she was born. She had:

• Trouble breathing and swallowing.
• A small heart defect.
• Very tight muscles (spasticity) and stiff joints (contractures).
• A tiny head (microcephaly) and severe developmental delays.
• Epilepsy: She had frequent, severe seizures starting right after birth that were very hard to stop with medicine.

Doctors ran standard genetic tests, but they came back "negative." It was like looking for a missing page in the manual and not finding it. So, the team used a much more powerful, high-tech microscope (Genome Sequencing) to look deeper.

The Discovery: The "Double-Page" Glitch

When they looked closely at the FBRSL1 chapter, they found something strange. It wasn't missing. Instead, the baby had a complex duplication.

The Analogy:
Imagine you are reading a book. Suddenly, the printer makes a mistake and pastes a second copy of the first half of a page right on top of the original page.

• The Original Page: Still there, trying to do its job.
• The Glitchy Copy: A partial, messy copy that overlaps the original.

In this baby's DNA, a large chunk of the chromosome was duplicated. One part of this duplication cut right through the middle of the FBRSL1 gene.

• The baby has two full, working copies of the gene (so it's not a "missing page" problem).
• BUT, she also has a third, broken, partial copy sitting right on top of them.

Why is this broken copy so bad?

The researchers realized this wasn't just "extra noise." It was a saboteur.

The Metaphor: The Bad Actor in a Play
Imagine a play where the actors (proteins) need to work together perfectly to build the brain.

• Normal Scenario: You have two good actors. They do their job.
• Previous Cases: One actor was missing (Haploinsufficiency). The play was weak, but the remaining actor tried their best.
• This Baby's Case: You have two good actors, PLUS a third actor who is wearing a mask and holding a script that is half-finished. This "bad actor" jumps in and gets in the way of the good actors, confusing the whole production.

This is called a Dominant-Negative mechanism. The broken copy doesn't just sit there; it actively interferes with the good copies, making the whole system fail. The RNA tests (checking the "scripts" the cells are reading) confirmed that this broken, extra copy was indeed being produced and was messing things up.

Why This Matters

1. It's a New Type of Error: Before this, we thought FBRSL1 problems were only caused by losing the gene. This paper proves that duplicating (copying) part of the gene can be just as dangerous, if not more so, because it creates a "saboteur."
2. The "Small" Matters: This duplication was very small (134,000 letters long). Standard genetic tests (like a "microarray") are like looking at a map from a plane; they can see big cities (huge deletions) but miss small towns. This baby's glitch was a "small town" that only a high-resolution satellite (Whole Genome Sequencing) could find.
3. Expanding the Diagnosis: This baby had a very severe form of epilepsy (Developmental and Epileptic Encephalopathy) that hadn't been linked to this gene before. Now, doctors know that if a baby has this specific mix of symptoms (breathing trouble, heart defects, stiff muscles, and severe seizures), they should look for this specific type of "copy-paste" error in the FBRSL1 gene.

The Takeaway

This paper is a detective story. The doctors found a baby with a severe mystery illness. They used advanced technology to find a tiny, complex "copy-paste" error in her DNA. They realized that this error created a broken protein that actively sabotaged the healthy ones.

This discovery helps doctors diagnose more babies in the future and teaches us that sometimes, having too much of a gene (or a messy copy of it) can be just as dangerous as having too little. It highlights the importance of using the most detailed genetic tools available to catch these tiny, hidden glitches.

Technical Summary

1. Problem Statement

• Clinical Gap: FBRSL1-related disorders were previously known to affect only five individuals, characterized by congenital malformations, severe developmental delay, and, in some cases, milder epilepsy. The full phenotypic and genotypic spectrum was unclear.
• Genetic Mechanism Uncertainty: Previous cases involved small truncating variants (nonsense/frameshift) that escaped nonsense-mediated decay (NMD). The mechanism was hypothesized to be either haploinsufficiency or a dominant-negative effect, but this was not definitively proven.
• Diagnostic Limitations: Standard clinical testing (like chromosomal microarray) often misses small structural variants (SVs), and short-read genome sequencing (GS) struggles to resolve complex, overlapping duplications.
• Objective: To identify the genetic etiology of a new patient with a severe, neonatal-onset Developmental and Epileptic Encephalopathy (DEE) and determine the molecular mechanism of FBRSL1 pathogenicity.

2. Methodology

The study employed a multi-modal genomic and transcriptomic approach to characterize a complex structural variant:

• Patient Cohort: A single female infant (Proband P6) with profound DEE, respiratory insufficiency, and dysmorphic features.
• Genome Sequencing (GS):
  • Short-Read WGS: Performed on the trio (proband + parents) using Illumina 151bp paired-end sequencing.
  • SV Calling: Utilized multiple callers (CNVnator for read-depth, Manta and Smoove for split-read/read-pair) to detect structural variants.
  • Re-analysis: The data was re-analyzed using a research pipeline covering all Mendelian disease genes (PanelApp Australia "Mendeliome").
• Validation & Refinement:
  • Droplet Digital PCR (ddPCR): Used to validate the copy number of the FBRSL1 5' region and determine parental origin.
  • Long-Read Sequencing: Oxford Nanopore Technologies (ONT) PromethION sequencing was used to resolve complex breakpoints that short reads could not clarify.
  • RNA Sequencing (RNA-Seq): Performed on blood-derived RNA to assess gene expression levels of the duplicated region compared to a healthy control.
• Bioinformatics:
  • Alignment to GRCh38/hg38.
  • Expression quantification using Salmon and statistical analysis via Mann-Whitney U test.
  • Integration of variant calls with population databases (gnomAD) and epilepsy gene panels.

3. Key Contributions

• Novel Genotype: Identification of the first de novo complex structural variant (two overlapping tandem duplications) at the FBRSL1 locus, expanding the genotypic spectrum beyond truncating variants.
• Novel Phenotype: Expansion of the FBRSL1 phenotypic spectrum to include severe, neonatal-onset Developmental and Epileptic Encephalopathy (DEE) with drug-resistant seizures and developmental regression, distinct from the milder epilepsy seen in previous cases.
• Mechanistic Insight: Provided strong evidence for a dominant-negative mechanism rather than haploinsufficiency. The variant creates a partial, truncated copy of the gene that is expressed and likely interferes with normal protein function.
• Methodological Demonstration: Highlighted the necessity of combining short-read GS, long-read sequencing, and RNA-Seq to resolve complex SVs that are invisible to standard clinical microarrays.

4. Results

• Clinical Presentation: The patient presented with intrauterine growth restriction, respiratory insufficiency, severe swallowing dysfunction, spasticity, contractures, optic nerve hypoplasia, and an atrial septal defect. Seizures began neonatally (focal impaired consciousness), evolved into infantile epileptic spasms (IESS) with hypsarrhythmia, and were highly drug-resistant.
• Genomic Findings:
  • Complex SV Structure: The variant consists of two overlapping duplications on the paternal chromosome 12:
    • DUP-389: 389 kb duplication.
    • DUP-134: 134 kb duplication.
    • Overlap: An 82 kb region is duplicated in both.
  • Gene Impact:
    • FBRSL1: The 134 kb duplication (DUP-134) encompasses the promoter, the first 5 exons of long isoforms, and all exons of short isoforms (3.1 and 3.2). This results in a partial duplication of the gene, creating an additional, truncated copy.
    • Other Genes: The larger duplication (DUP-389) fully duplicates NOC4L, DDX51, and GALNT9, and includes the 3' UTR of EP400.
• Expression Analysis:
  • RNA-Seq confirmed increased expression of the duplicated FBRSL1 exons and the upstream intergenic region in the proband compared to controls.
  • This confirms that the truncated copy is transcribed and likely translated, supporting a dominant-negative model where the aberrant protein competes with the wild-type protein.
• Phenotypic Comparison: The patient shares core features with previous FBRSL1 cases (microcephaly, contractures, heart defects, facial dysmorphism) but exhibits a much more severe neurological course (neonatal onset, regression, intractable DEE) compared to the milder epilepsy seen in previous truncating variant cases.

5. Significance

• Redefining FBRSL1 Disorders: This case establishes that FBRSL1 mutations can cause severe, neonatal-onset DEE, not just congenital malformation syndromes with milder epilepsy.
• Mechanism Clarification: The findings suggest that FBRSL1 pathogenicity is driven by a dominant-negative effect of truncated proteins (or aberrant fusion proteins) rather than simple loss of function (haploinsufficiency). This is supported by the fact that the patient has two intact alleles plus a partial, expressed copy.
• Clinical Implications:
  • Diagnostic Yield: Emphasizes that small duplications (<134 kb) are pathogenic and can be missed by chromosomal microarray (CMA).
  • Testing Strategy: Advocates for the integration of long-read sequencing and RNA-Seq into diagnostic workflows for complex cases where short-read GS yields ambiguous SVs.
  • Phenotype-Genotype Correlation: Demonstrates that detailed phenotypic matching (e.g., respiratory insufficiency, contractures) is crucial for identifying rare disease associations when genetic variants are complex.
• Future Directions: Highlights the need for functional studies to understand how the truncated FBRSL1 protein disrupts embryonic development and chromatin regulation (specifically regarding BRPF1 and KAT6A).